Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4242768
Max Phase: Preclinical
Molecular Formula: C55H105N17O10
Molecular Weight: 1164.55
Molecule Type: Small molecule
Associated Items:
ID: ALA4242768
Max Phase: Preclinical
Molecular Formula: C55H105N17O10
Molecular Weight: 1164.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C)C(N)=O
Standard InChI: InChI=1S/C55H105N17O10/c1-14-34(12)44(45(57)74)72-48(77)38(21-18-24-63-55(60)61)65-46(75)36(19-15-16-22-56)67-53(82)43(33(10)11)71-47(76)37(20-17-23-62-54(58)59)66-50(79)40(26-30(4)5)69-52(81)42(28-32(8)9)70-51(80)41(27-31(6)7)68-49(78)39(25-29(2)3)64-35(13)73/h29-34,36-44H,14-28,56H2,1-13H3,(H2,57,74)(H,64,73)(H,65,75)(H,66,79)(H,67,82)(H,68,78)(H,69,81)(H,70,80)(H,71,76)(H,72,77)(H4,58,59,62)(H4,60,61,63)/t34-,36-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1
Standard InChI Key: LXDWQPBYWAMHHV-BNMZFGTOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1164.55 | Molecular Weight (Monoisotopic): 1163.8230 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):